1. Corporate Officers - D
2. Dubensky Thomas W.

Insider Trading History of Dubensky Thomas W.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Dubensky Thomas W. since 2015. This trader's CIK number is 1635590. At the time of last reporting, Dubensky Thomas W. was the President of Tempest Therapeutics, Inc.. (stock ticker symbol TPST). Also see all insider trading activities at Tempest Therapeutics, Inc..

Note that in the past Dubensky Thomas W. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Chinook Therapeutics, Inc. (ADRO) by Dubensky Thomas W.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	ADRO	0	$0	300,000	$3,193,235	300,000	$187,747
2016	ADRO	0	$0	190,905	$2,660,020	190,000	$231,375
2015	ADRO	0	$0	61,470	$1,773,073	60,000	$137,009

Yearly summary of insider trading at Tempest Therapeutics, Inc. (TPST) by Dubensky Thomas W.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2022	TPST	2,000	$9,560	0	$0	0	$0

Insider trading activities at 2 companies by Dubensky Thomas W.:

1. Chinook Therapeutics, Inc. (ADRO)

2. Tempest Therapeutics, Inc. (TPST)

Table 1. Insider trading of Chinook Therapeutics, Inc. (ADRO) by Dubensky Thomas W.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-08-10	ADRO	Option Ex	40,912	1.00	40,912
2017-08-11	ADRO	Option Ex	9,088	1.00	9,088
2017-08-10	ADRO	Sale	40,912	11.43	467,665
2017-08-11	ADRO	Sale	9,088	11.17	101,540
2017-07-05	ADRO	Option Ex	33,688	.52	17,517
2017-07-03	ADRO	Sale	11,800	11.02	130,024
2017-07-03	ADRO	Option Ex	11,800	.52	6,136
2017-07-06	ADRO	Sale	4,512	11.23	50,674
2017-07-05	ADRO	Sale	33,688	11.46	385,929
2017-07-06	ADRO	Option Ex	4,512	.52	2,346
2017-06-05	ADRO	Sale	17,577	9.99	175,629
2017-06-05	ADRO	Option Ex	17,577	.52	9,140
2017-06-02	ADRO	Sale	48,753	10.10	492,307
2017-06-01	ADRO	Sale	77,971	10.00	779,865
2017-06-02	ADRO	Option Ex	48,753	.52	25,351
2017-06-01	ADRO	Option Ex	77,971	.52	40,544
2017-05-12	ADRO	Option Ex	4,299	.52	2,235
2017-05-11	ADRO	Option Ex	1,400	.52	728
2017-05-11	ADRO	Sale	1,400	9.91	13,869
2017-05-12	ADRO	Sale	4,299	9.92	42,658
2017-03-09	ADRO	Option Ex	25,000	.83	20,750
2017-03-09	ADRO	Sale	25,000	10.96	274,075
2017-01-03	ADRO	Option Ex	25,000	.52	13,000
2017-01-03	ADRO	Sale	25,000	11.16	279,000
2016-12-01	ADRO	Sale	25,000	10.94	273,500
2016-12-01	ADRO	Option Ex	25,000	.83	20,750
2016-12-01	ADRO	Sale	25,000	10.94	273,500
2016-12-01	ADRO	Option Ex	25,000	.83	20,750
2016-11-10	ADRO	Option Ex	25,000	.98	24,625
2016-11-10	ADRO	Sale	25,000	14.78	369,400
2016-10-03	ADRO	Option Ex	25,000	.98	24,625
2016-10-03	ADRO	Sale	25,000	12.68	316,900
2016-09-01	ADRO	Option Ex	25,000	.98	24,625
2016-09-01	ADRO	Sale	25,000	14.03	350,775
2016-08-11	ADRO	Option Ex	25,000	.98	24,625
2016-08-11	ADRO	Sale	25,000	15.18	379,500
2016-07-05	ADRO	Option Ex	25,000	.98	24,625
2016-07-05	ADRO	Sale	25,000	11.61	290,250
2016-05-16	ADRO	Sale	905	8.20	7,420
2016-01-04	ADRO	Option Ex	15,000	4.45	66,750
2016-01-04	ADRO	Sale	15,000	26.59	398,775
2015-12-01	ADRO	Sale	30,000	29.66	889,740
2015-12-01	ADRO	Option Ex	30,000	3.12	93,510
2015-11-16	ADRO	Option Ex	9,481	1.45	13,747
2015-11-17	ADRO	Option Ex	20,519	1.45	29,752
2015-11-16	ADRO	Sale	10,951	27.78	304,185
2015-11-17	ADRO	Sale	20,519	28.23	579,148

Table 2. Insider trading of Tempest Therapeutics, Inc. (TPST) by Dubensky Thomas W.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2022-01-07	TPST	Buy	2,000	4.78	9,560

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dubensky Thomas W. (President of Tempest Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month